Catalysts for Reata Pharmaceuticals Inc
5 tracked
Apr 7, 2026
approval
SKYCLARYS (OMAVELOXOLONE) — FDA approval
Reata Pharmaceuticals Inc
→
Dec 20, 2024
approval
SKYCLARYS (OMAVELOXOLONE) — FDA approval
Reata Pharmaceuticals Inc
→
Dec 20, 2024
approval
SKYCLARYS (OMAVELOXOLONE) — FDA approval
Reata Pharmaceuticals Inc
→
Jan 25, 2024
approval
SKYCLARYS (OMAVELOXOLONE) — FDA approval
Reata Pharmaceuticals Inc
→
Feb 28, 2023
approval
SKYCLARYS (OMAVELOXOLONE) — FDA approval
Reata Pharmaceuticals Inc
→